Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising EryKit, Syringe Kit, drugs, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

Quince Therapeutics Inc.

Analysts are intrested in these 5 stocks: ( ($BHVN) ), ( ($QNCX) ), ( ($IRDM) ), ( ($EJTTF) ) and ( ($LOGI) ). Here is a breakdown of their recent


Biohaven, Quince, Iridium, EasyJet, Logitech Trending by Analysts

Let’s take a look at the upcoming stock splits for the week of June 29 to July 3, based on TipRanks’ Stock Splits Calendar. Stock splits are among ...

Upcoming Stock Splits This Week (June 29 to July 3) – Stay Invested

Analysts are intrested in these 5 stocks: ( ($TTWO) ), ( ($QNCX) ), ( ($TNXP) ), ( ($CRWV) ) and ( ($AFRM) ). Here is a breakdown of their recent


Take-Two, Quince, Tonix, CoreWeave, Affirm Trending With Analysts

Quince Therapeutics ( ($QNCX) ) has issued an update. On June 11, 2026, stockholders of Quince Therapeutics approved a reverse stock split at a rat...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	QNCX	$18.58	-3.68%	39.59K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	QNCX	$18.58	-3.7%	39.59K
3
4
5
6

QNCX

QNCX

Get Quince Therapeutics Inc. Data in Excel

Get Quince Therapeutics Inc. Data in Excel